Literature DB >> 9245820

Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function.

M L Turcotte1, Denis Martin2, Bernard R Brodeur2, Mark S Peppler.   

Abstract

An LPSB-specific mAb was used to screen for ten Tn5 insertion mutants of Bordetella pertussis which have LPS which is phenotypically distinct from either wild-type LPSAB or LPSB. Silver-strained SDS-PAGE gels showed nine different LPS phenotypes, six of which contain two clinically undocumented LPS bands, designated IntA and IntB based on their proximity to the LPSA and LPSB bands, respectively. Binding assays with LPSA- and LPSB-specific mAbs established changes in epitope exposure for the various mutant LPS, both in cell-free form and as presented on the surface of whole cells. The possible involvement of a number of genes, both structural and regulatory, was indicated in production of the altered phenotypes. PFGE and Southern blotting showed that the Tn5 inserts of seven mutants mapped to a region of the B. pertussis chromosome shown previously to encode the bpl gene products of LPS biosynthesis. Mutants MLT3, MLT5 and MLT8, however, mapped to distinctly different parts of the chromosome. In addition, mutants MLT2 and MLT3 contributed to an accelerated frequency in the appearance of avirulent phase organisms despite their Tn5 inserts being over 1000 bp from the bvglASR locus. The alterations in LPS structure in the mutants changed their reactivity to strain-specific mAbs and their sensitivity to hydrophobic and hydrophilic antibiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245820     DOI: 10.1099/00221287-143-7-2381

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  7 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection.

Authors:  E T Harvill; A Preston; P A Cotter; A G Allen; D J Maskell; J F Miller
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate.

Authors:  Tomasz Niedziela; Iwona Letowska; Jolanta Lukasiewicz; Marta Kaszowska; Anna Czarnecka; Lennart Kenne; Czeslaw Lugowski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides.

Authors:  A Banemann; H Deppisch; R Gross
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Comparison of bipA alleles within and across Bordetella species.

Authors:  Bryna Fuchslocher; Laura L Millar; Peggy A Cotter
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Characterization of human bactericidal antibodies to Bordetella pertussis.

Authors:  A A Weiss; P S Mobberley; R C Fernandez; C M Mink
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.